09-17-2018 | Prediabetes | medwireNews | News
Upfront treatment with medications that target the underlying pathophysiology of prediabetes may slow patients’ progression to type 2 diabetes, report researchers.
10-24-2017 | Pioglitazone | News
Observational findings suggest that pioglitazone use may be associated with a reduced risk for gout among patients with diabetes.
09-13-2017 | Pioglitazone | EASD 2017 | News
The TOCSA.IT investigators have found no differences in cardiovascular disease outcomes between patients with type 2 diabetes taking pioglitazone versus sulfonylurea over nearly 5 years.
08-03-2017 | Ipragliflozin | News
06-09-2018 | Cardiovascular disorders | Review | Article
Khat DZ, Husain M. Curr Diab Rep 2018; 18: 45. doi: 10.1007/s11892-018-1011-7
06-08-2018 | Insulin resistance | Review | Article
Dave N, Wu J, Thomas S. Curr Diab Rep 2018; 18: 44. doi: 10.1007/s11892-018-1010-8
05-18-2018 | Gestational diabetes | Review | Article
Yeung RO et al. Rev Endocr Metab Disord 2018. doi: 10.1007/s11154-018-9446-3